Lung expression quantitative trait loci data set identifies important functional polymorphisms in the asthma-associated IL1RL1 region

Loubna Akhabir; Jean Christophe Bérubé; Yohan Bossé; Michel Laviolette; Ke Hao; David C. Nickle; Wim Timens; Don D. Sin; Peter D. Paré; Dirkje S. Postma; Andrew J. Sandford

doi:10.1016/j.jaci.2014.02.039

Lung expression quantitative trait loci data set identifies important functional polymorphisms in the asthma-associated IL1RL1 region

Loubna Akhabir
, Jean Christophe Bérubé
, Yohan Bossé
, Michel Laviolette
, Ke Hao
, David C. Nickle
, Wim Timens
, Don D. Sin
, Peter D. Paré
, Dirkje S. Postma
, Andrew J. Sandford

Research output: Contribution to journal › Article › peer-review

16 Scopus citations

Original language	English
Pages (from-to)	729-731
Number of pages	3
Journal	Journal of Allergy and Clinical Immunology
Volume	134
Issue number	3
DOIs	https://doi.org/10.1016/j.jaci.2014.02.039
State	Published - Sep 2014
Externally published	Yes

Access to Document

10.1016/j.jaci.2014.02.039

Cite this

Akhabir, L., Bérubé, J. C., Bossé, Y., Laviolette, M., Hao, K., Nickle, D. C., Timens, W., Sin, D. D., Paré, P. D., Postma, D. S., & Sandford, A. J. (2014). Lung expression quantitative trait loci data set identifies important functional polymorphisms in the asthma-associated IL1RL1 region. Journal of Allergy and Clinical Immunology, 134(3), 729-731. https://doi.org/10.1016/j.jaci.2014.02.039

@article{07b5d3b104594941a40ef47ad65e8391,

title = "Lung expression quantitative trait loci data set identifies important functional polymorphisms in the asthma-associated IL1RL1 region",

author = "Loubna Akhabir and B{\'e}rub{\'e}, \{Jean Christophe\} and Yohan Boss{\'e} and Michel Laviolette and Ke Hao and Nickle, \{David C.\} and Wim Timens and Sin, \{Don D.\} and Par{\'e}, \{Peter D.\} and Postma, \{Dirkje S.\} and Sandford, \{Andrew J.\}",

note = "Funding Information: Disclosure of potential conflict of interest: M. Laviolette has received consultancy fees from Novartis and Boston Scientific. D. C. Nickle is employed by Merck \& Co. W. Timens has received consultancy fees from Pfizer; has received lecture fees from GlaxoSmithKline, Chiesi, and Roche Diagnostics; and has received research support from Pfizer, GlaxoSmithKline, Chiesi, Roche Diagnostics, and the Dutch Asthma Fund. D. D. Sin is a board member for Merck Frosst, Almirall, Nycomed, Talecris, and Novartis; has received research support from AstraZeneca; has received lecture fees from GlaxoSmithKline and Nycomed; and has received payment for development of educational presentations from AstraZeneca. D. S. Postma has received consultancy fees from Astra Zeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Takeda, and TEVA; has received research support and lecture fees from Chiesi. A. J. Sandford has received research support from AllerGen NCE. The rest of the authors declare that they have no relevant conflicts of interest. ",

year = "2014",

month = sep,

doi = "10.1016/j.jaci.2014.02.039",

language = "English",

volume = "134",

pages = "729--731",

journal = "Journal of Allergy and Clinical Immunology",

issn = "0091-6749",

publisher = "Elsevier Inc.",

number = "3",

}

Akhabir, L, Bérubé, JC, Bossé, Y, Laviolette, M, Hao, K, Nickle, DC, Timens, W, Sin, DD, Paré, PD, Postma, DS & Sandford, AJ 2014, 'Lung expression quantitative trait loci data set identifies important functional polymorphisms in the asthma-associated IL1RL1 region', Journal of Allergy and Clinical Immunology, vol. 134, no. 3, pp. 729-731. https://doi.org/10.1016/j.jaci.2014.02.039

TY - JOUR

T1 - Lung expression quantitative trait loci data set identifies important functional polymorphisms in the asthma-associated IL1RL1 region

AU - Akhabir, Loubna

AU - Bérubé, Jean Christophe

AU - Bossé, Yohan

AU - Laviolette, Michel

AU - Hao, Ke

AU - Nickle, David C.

AU - Timens, Wim

AU - Sin, Don D.

AU - Paré, Peter D.

AU - Postma, Dirkje S.

AU - Sandford, Andrew J.

N1 - Funding Information: Disclosure of potential conflict of interest: M. Laviolette has received consultancy fees from Novartis and Boston Scientific. D. C. Nickle is employed by Merck & Co. W. Timens has received consultancy fees from Pfizer; has received lecture fees from GlaxoSmithKline, Chiesi, and Roche Diagnostics; and has received research support from Pfizer, GlaxoSmithKline, Chiesi, Roche Diagnostics, and the Dutch Asthma Fund. D. D. Sin is a board member for Merck Frosst, Almirall, Nycomed, Talecris, and Novartis; has received research support from AstraZeneca; has received lecture fees from GlaxoSmithKline and Nycomed; and has received payment for development of educational presentations from AstraZeneca. D. S. Postma has received consultancy fees from Astra Zeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, Takeda, and TEVA; has received research support and lecture fees from Chiesi. A. J. Sandford has received research support from AllerGen NCE. The rest of the authors declare that they have no relevant conflicts of interest.

PY - 2014/9

Y1 - 2014/9

UR - https://www.scopus.com/pages/publications/84906944147

U2 - 10.1016/j.jaci.2014.02.039

DO - 10.1016/j.jaci.2014.02.039

M3 - Article

C2 - 24746754

AN - SCOPUS:84906944147

SN - 0091-6749

VL - 134

SP - 729

EP - 731

JO - Journal of Allergy and Clinical Immunology

JF - Journal of Allergy and Clinical Immunology

IS - 3

ER -